Cited by 911Smoking Behavior and CessationPoisoning and overdose treatmentsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin—Final Report

Layden, Jennifer E., Ghinai, Isaac, Pray, Ian, Kimball, Anne, Layer, Mark, Tenforde, Mark W., Navon, Livia, Hoots, Brooke +10 more·2020·New England Journal of Medicine

Abstract

BACKGROUND: E-cigarettes are battery-operated devices that heat a liquid and deliver an aerosolized product to the user. Pulmonary illnesses related to e-cigarette use have been reported, but no large series has been described. In July 2019, the Wisconsin Department of Health Services and the Illinois Department of Public Health received reports of lung injury associated with the use of e-cigarettes (also called vaping) and launched a coordinated public health investigation. METHODS: We defined case patients as persons who reported use of e-cigarette devices and related products in the 90 days before symptom onset and had pulmonary infiltrates on imaging and whose illnesses were not attributed to other causes. Medical record abstraction and case patient interviews were conducted with the use of standardized tools. RESULTS: There were 98 case patients, 79% of whom were male; the median age of the patients was 21 years. The majority of patients presented with respiratory symptoms (97%), gastrointestinal symptoms (77%), and constitutional symptoms (100%). All case patients had bilateral infiltrates on chest imaging. A total of 95% of the patients were hospitalized, 26% underwent intubation and mechanical ventilation, and two deaths were reported. A total of 89% of the patients reported having used tetrahydrocannabinol products in e-cigarette devices, although a wide variety of products and devices was reported. Syndromic surveillance data from Illinois showed that the mean monthly rate of visits related to severe respiratory illness in June through August of 2019 was twice the rate that was observed in the same months in 2018. CONCLUSIONS: Case patients presented with similar clinical characteristics. Although the definitive substance or substances contributing to injury have not been determined, this initial cluster of illnesses represents an emerging clinical syndrome or syndromes. Additional work is needed to characterize the pathophysiology and to identify the definitive causes.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1911614

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early initiation into vaping increases the risk of lifelong nicotine dependence, which is associated with respiratory illnesses including EVALI, cardiovascular disease, and other non-communicable conditions.

    “The campaign stressed that early initiation into vaping increases the risk of lifelong nicotine dependence, which is associated with respiratory illnesses (including EVALI), cardiovascular disease, and other non-communicable conditions [25,26].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Layden, J. E., Ghinai, I., Pray, I., Kimball, A., Layer, M., Tenforde, M. W., Navon, L., Hoots, B., Salvatore, P. P., Elderbrook, M., Haupt, T., Kanne, J., Patel, M. T., Saathoff-Huber, L., King, B. A., Schier, J. G., Mikosz, C. A., & Meiman, J.
Affiliations
  • Illinois Department of Public Health (US)
  • Wisconsin Department of Health Services (US)
  • Centers for Disease Control and Prevention (US)
  • From the Illinois Department of Public Health, Springfield (J.E.L., I.G., L.N., M.T.P., L.S.-H.); the Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services (I.G., I.P., A.K., M.W.T., P.P.S.), National Center for Environmental Health (M.L.), the Division of State and Local Readiness, Center for Preparedness and Response (L.N.), the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control (B.H., J.G.S., C.A.M.), and the...
Venue
New England Journal of Medicine
Published
2020-03-05
Volume
382
Issue
10
Pages
903-916
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2971846128
Cited by
911
References
1
Citations by year
2026: 42 · 2025: 51 · 2024: 71 · 2023: 78 · 2022: 109 · 2021: 153 · 2020: 311 · 2019: 93 · 2014: 1
FWCI
114.22
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Keywords
vaping, lung injury, tetrahydrocannabinol, cannabis vaping, bilateral pulmonary infiltrates, severe respiratory disease, syndromic surveillance, clinical features, Illinois, Wisconsin
MeSH terms
Vaping, Adolescent, Adult, Disease Outbreaks, Female, Hospitalization, Humans, Illinois, Leukocytosis, Lung, Male, Middle Aged, Population Surveillance, Dronabinol, Radiography, Thoracic, Wisconsin, Lung Injury, Young Adult, Electronic Nicotine Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review